🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests the safety, side effects, and best dose of triapin...
Status
Recruiting
Location
Northwestern University
Start Date
2024-07-23
Trial ID
NCT06410248
Fifteen subjects with intermittent exotropia were included. The subjects we...
Status
Unknown
Location
Busan Paik hospital
Start Date
2017-12-21
Trial ID
NCT03641040
Treatments Being Tested
This randomized phase III trial studies radiation therapy and cisplatin wit...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-05-10
Trial ID
NCT02466971
This phase I trial studies the side effects and best dose of triapine when ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-07-20
Trial ID
NCT04234568
This phase I trial tests the safety, side effects, and best dose of triapin...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2025-07-30
Trial ID
NCT06860594
This early phase I trial investigates the response to the anti-cancer drug,...
Status
Active Not Recruiting
Location
UM Sylvester Comprehensive Cancer Center at Coral Gables
Start Date
2022-02-08
Trial ID
NCT04494113
Treatments Being Tested
Thirty-four subjects with constant exotropia were included. Two independent...
Status
Completed
Location
Busan Paik hospital
Start Date
2017-04-25
Trial ID
NCT03119311
Treatments Being Tested
This phase I trial studies the side effects and best dose of triapine when ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-09-18
Trial ID
NCT02595879
This phase II trial compares the effect of adding triapine to lutetium Lu 1...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2023-08-30
Trial ID
NCT05724108